Copyright
©The Author(s) 2019.
World J Gastroenterol. Jul 21, 2019; 25(27): 3649-3663
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3649
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3649
Author (year) | Country | Control | Immuno-therapy interven-tions | Patients | Child-Pugh score A/B/C | Immune cell regimens | Course | ||
Control | Trial | Control | Trial | ||||||
Nakamoto (2007)[19] | Japan | TACE | TACE + DC | 11 | 10 | 4/7/0 | 8/2/0 | 5 × 106 | 1 |
Nakamoto (2011)[20] | Japan | TACE | TACE + DC | 22 | 13 | NR | 5/8/0 | 5 × 106 | 1 |
El Ansary (2013)[21] | Egypt | Supportive treatment | DC | 15 | 15 | 0/14/1 | 0/15/0 | 20 × 106 | 1 |
Sun (2015)[22] | China | Resection + FOLFOX6 | Resection + DC | 80 | 80 | NR | NR | 8.9 × 109 | 6 |
Lee (2017)[23] | South Korea | Resection/RFA/PEI | Resection/RFA/PEI + DC | 75 | 69 | NR | NR | 3 × 107 | 6 |
Weng (2007)[24] | China | TACE + RFA | TACE + RFA + CIK | 40 | 45 | 33/7/0 | 36/9/0 | 1.0-1.5 × 1010 | 8/9 |
Dong (2008)[25] | China | Resection | Resection + CIK | 43 | 84 | 34/9/0 | 68/16/0 | 1.0-2.0 × 1010 | 3/5 |
Hao (2010)[26] | China | TACE | TACE + RFA + CIK | 74 | 72 | 66/8/0 | 65/7/0 | 1.0-5.0 × 1010 | 4 |
Pan (2010)[27] | China | TACE + RFA | TACE + RFA + CIK | 39 | 42 | NR | NR | 1.0 × 1010 | 4 |
Pan (2013)[28] | China | Resection | Resection + CIK | 206 | 204 | 206/0/0 | 204/0/0 | 1.0-1.5 × 1010 | 4 |
Lee (2015)[29] | South Korea | Resection/RFA/PEI | Resection/RFA/PEI + CIK | 112 | 114 | 112/0/0 | 114/0/0 | NR | 16 |
Pan (2015)[30] | China | Resection | Resection + CIK | 520 | 511 | NR | NR | 1.0-1.5 × 1010 | 4 |
Chen (2016)[31] | China | Resection | Resection + CIK | 118 | 231 | 205/12/0 | 222/9/0 | 1.0-1.5 × 1010 | 4 |
Li (2016)[32] | China | Oxaliplatin + Capecitabine | CIK | 37 | 37 | 33(A + B)/4(C) | 27(A + B)/10(C) | NR | NR |
Chang (2018)[33] | China | Resection | Resection + CIK | 145 | 145 | 145/0/0 | 145/0/0 | NR | NR |
Lee (2018)[34] | South Korea | Resection/RFA/PEI | Resection/RFA/PEI + CIK | 112 | 114 | 112/0/0 | 114/0/0 | 6.4 × 109 | 16 |
Cui (2014)[35] | China | RFA | RFA + NK/γδT/CIK | 32 | 30 | 14/18/0 | 18/12/0 | 1.2-2.0 × 109 | 8 |
Qian (2016)[36] | China | RFA | RFA + NK/γδT/CIK | 31 | 73 | NR | NR | 1.0-2.0 × 109 | 8 |
Qiu (2011)[37] | China | Resection | Resection + DC/CIK | 9 | 9 | NR | NR | 2.0-20.0 × 109 | NR |
Niu (2013)[38] | China | Cryoablation | Cytotherapy + DC/CIK | 12 | 21 | NR | NR | 6.0-10.0 × 109 | NR |
Shimizu (2014)[39] | Japan | Resection | Resection + DC/CIK | 40 | 35 | 44/8/0 | 34/8/0 | NR | NR |
Yu (2015)[40] | China | Microwave ablation | Microwave ablation + DC/CIK | 15 | 14 | 15/0/0 | 13/1/0 | NR | NR |
- Citation: Cao J, Kong FH, Liu X, Wang XB. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2019; 25(27): 3649-3663
- URL: https://www.wjgnet.com/1007-9327/full/v25/i27/3649.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i27.3649